{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:28:44Z","timestamp":1792106924350,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070455"],"award-info":[{"award-number":["82070455"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Health Commission Project","award":["M2020016"],"award-info":[{"award-number":["M2020016"]}]},{"name":"the Open Project Program of Guangxi Key Laboratory of Centre of Diabetic Systems Medicine","award":["GKLCDSM-20210101-02"],"award-info":[{"award-number":["GKLCDSM-20210101-02"]}]},{"name":"Postgraduate Research\uff06Practice Innovation Program of Jiangsu Province","award":["KYCX20_3051"],"award-info":[{"award-number":["KYCX20_3051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10719-023-10106-x","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T16:30:35Z","timestamp":1677169835000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of galectin-3 in vascular calcification"],"prefix":"10.1007","volume":"40","author":[{"given":"Yaoyao","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"10106_CR1","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Lee, I.K., Jeon, J.H.: Vascular calcification-new insights into its mechanism.\u00a0Int. J. Mol. Sci.\u00a021(8) (2020)","DOI":"10.3390\/ijms21082685"},{"key":"10106_CR2","doi-asserted-by":"crossref","unstructured":"Ibarrola, J., Mart\u00ednez-Mart\u00ednez, E., S\u00e1daba, J.R., Arrieta, V., Garc\u00eda-Pe\u00f1a, A., \u00c1lvarez, V., et al.: Beneficial effects of galectin-3 blockade in vascular and aortic valve alterations in an experimental pressure overload model. Int. J. Mol. Sci.\u00a018(8) (2017)","DOI":"10.3390\/ijms18081664"},{"issue":"5","key":"10106_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MCA.0000000000000252","volume":"26","author":"D Ozturk","year":"2015","unstructured":"Ozturk, D., Celik, O., Satilmis, S., Aslan, S., Erturk, M., Cakmak, H.A., et al.: Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden\/structure in patients with type 2 diabetes mellitus. Coron. Artery Dis. 26(5), 396\u2013401 (2015)","journal-title":"Coron. Artery Dis."},{"key":"10106_CR4","doi-asserted-by":"crossref","unstructured":"S\u00e1daba, J.R., Mart\u00ednez-Mart\u00ednez, E., Arrieta, V., \u00c1lvarez, V., Fern\u00e1ndez-Celis, A., Ibarrola, J., et al.: Role for galectin-3 in calcific aortic valve stenosis.\u00a0J. Am. Heart Assoc. 5(11) (2016)","DOI":"10.1161\/JAHA.116.004360"},{"issue":"3","key":"10106_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvt206","volume":"100","author":"S Menini","year":"2013","unstructured":"Menini, S., Iacobini, C., Ricci, C., Blasetti Fantauzzi, C., Salvi, L., Pesce, C.M., et al.: The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc. Res. 100(3), 472\u2013480 (2013)","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10106_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/cdt-21-506","volume":"12","author":"J Luo","year":"2022","unstructured":"Luo, J., Wang, S., Liu, X., Zheng, Q., Wang, Z., Huang, Y., et al.: Galectin-3 promotes calcification of human aortic valve interstitial cells via the NF-kappa B signaling pathway. Cardiovasc. Diagn. Ther. 12(2), 196\u2013207 (2022)","journal-title":"Cardiovascular Diagnosis and Therapy."},{"key":"10106_CR7","doi-asserted-by":"crossref","unstructured":"Ho, M.K.: Springer TA. Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies.\u00a0J. Immunol.\u00a0(Baltimore, Md : 1950). 128(3), 1221\u20138 (1982)","DOI":"10.4049\/jimmunol.128.3.1221"},{"key":"10106_CR8","doi-asserted-by":"crossref","unstructured":"Cowles, E.A., Agrwal, N., Anderson, R.L., Wang, J.L.: Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative.\u00a0J. Biol. Chem. 265(29), 17706\u201312 (1990)","DOI":"10.1016\/S0021-9258(18)38221-8"},{"issue":"2","key":"10106_CR9","first-page":"599","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong, R., Zhang, M., Hu, Q., Zheng, S., Soh, A., Zheng, Y., et al.: Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int. J. Mol. Med. 41(2), 599\u2013614 (2018)","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10106_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1515\/cclm-2014-0187","volume":"52","author":"G Pugliese","year":"2014","unstructured":"Pugliese, G., Iacobini, C., Ricci, C., Blasetti Fantauzzi, C., Menini, S.: Galectin-3 in diabetic patients. Clin. Chem. Lab. Med. 52(10), 1413\u20131423 (2014)","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10106_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","volume":"313","author":"AU Newlaczyl","year":"2011","unstructured":"Newlaczyl, A.U., Yu, L.G.: Galectin-3\u2013a jack-of-all-trades in cancer. Cancer Lett. 313(2), 123\u2013128 (2011)","journal-title":"Cancer Lett."},{"key":"10106_CR12","doi-asserted-by":"crossref","unstructured":"Cano-Meg\u00edas, M., Bouarich, H., Guisado-Vasco, P., P\u00e9rez Fern\u00e1ndez, M., de Arriba-de la Fuente, G., \u00c1lvarez-Sanz, C., et al.: Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease.\u00a0Endocrinol. Diabetes Nutr. 66(5), 297\u2013304 (2019)","DOI":"10.1016\/j.endien.2018.09.003"},{"issue":"2","key":"10106_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","volume":"37","author":"K Yahagi","year":"2017","unstructured":"Yahagi, K., Kolodgie, F.D., Lutter, C., Mori, H., Romero, M.E., Finn, A.V., et al.: Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 37(2), 191\u2013204 (2017)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10106_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13098-019-0464-4","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang, L., Sun, H., Liu, S., Gao, J., Xia, J.: Glycemic variability is associated with vascular calcification by the markers of endoplasmic reticulum stress-related apoptosis, Wnt1, galectin-3 and BMP-2. Diabetol. Metab. Syndr. 11, 67 (2019)","journal-title":"Diabetol. Metab. Syndr."},{"issue":"6","key":"10106_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ackd.2019.08.014","volume":"26","author":"S Disthabanchong","year":"2019","unstructured":"Disthabanchong, S., Srisuwarn, P.: Mechanisms of vascular calcification in kidney disease. Adv. Chronic Kidney Dis. 26(6), 417\u2013426 (2019)","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"4","key":"10106_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","volume":"93","author":"M Wu","year":"2013","unstructured":"Wu, M., Rementer, C., Giachelli, C.M.: Vascular calcification: an update on mechanisms and challenges in treatment. Calcif. Tissue Int. 93(4), 365\u2013373 (2013)","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10106_CR17","doi-asserted-by":"publisher","first-page":"H364","DOI":"10.1152\/ajpheart.00523.2020","volume":"320","author":"Z Sun","year":"2021","unstructured":"Sun, Z., Zhang, L., Li, L., Shao, C., Liu, J., Zhou, M., et al.: Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt. Am. J. Physiol. Heart Circ. Physiol. 320(1), H364\u2013H380 (2021)","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10106_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1172\/JCI86924","volume":"127","author":"SR Langley","year":"2017","unstructured":"Langley, S.R., Willeit, K., Didangelos, A., Matic, L.P., Skroblin, P., Barallobre-Barreiro, J., et al.: Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. J. Clin. Investig. 127(4), 1546\u20131560 (2017)","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10106_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","volume":"28","author":"M Papaspyridonos","year":"2008","unstructured":"Papaspyridonos, M., McNeill, E., de Bono, J.P., Smith, A., Burnand, K.G., Channon, K.M., et al.: Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler. Thromb. Vasc. Biol. 28(3), 433\u2013440 (2008)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10106_CR20","first-page":"1199","volume":"152","author":"M Nachtigal","year":"1998","unstructured":"Nachtigal, M., Al-Assaad, Z., Mayer, E.P., Kim, K., Monsigny, M.: Galectin-3 expression in human atherosclerotic lesions. Am. J. Pathol. 152(5), 1199\u20131208 (1998)","journal-title":"Am. J. Pathol."},{"key":"10106_CR21","doi-asserted-by":"crossref","unstructured":"Iacobini, C., Blasetti Fantauzzi, C., Bedini, R., Pecci, R., Bartolazzi, A., Amadio, B., et al.: Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.\u00a0Metab. Clin. Exp.\u00a083, 149\u201358 (2018)","DOI":"10.1016\/j.metabol.2018.02.001"},{"key":"10106_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2016.01.022","volume":"246","author":"A Lisowska","year":"2016","unstructured":"Lisowska, A., Knapp, M., Tyci\u0144ska, A., Motybel, E., Kami\u0144ski, K., \u015awi\u0119cki, P., et al.: Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study. Atherosclerosis 246, 309\u2013317 (2016)","journal-title":"Atherosclerosis"},{"issue":"4","key":"10106_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/039463201102400409","volume":"24","author":"C Falcone","year":"2011","unstructured":"Falcone, C., Lucibello, S., Mazzucchelli, I., Bozzini, S., D\u2019Angelo, A., Schirinzi, S., et al.: Galectin-3 plasma levels and coronary artery disease: a new possible biomarker of acute coronary syndrome. Int. J. Immunopathol. Pharmacol. 24(4), 905\u2013913 (2011)","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"4","key":"10106_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00592-018-1273-1","volume":"56","author":"Z Sun","year":"2019","unstructured":"Sun, Z., Wang, Z., Li, L., Yan, J., Shao, C., Bao, Z., et al.: RAGE\/galectin-3 yields intraplaque calcification transformation via sortilin. Acta Diabetol. 56(4), 457\u2013472 (2019)","journal-title":"Acta Diabetol."},{"issue":"1","key":"10106_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejvs.2014.10.009","volume":"49","author":"NP Kadoglou","year":"2015","unstructured":"Kadoglou, N.P., Sfyroeras, G.S., Spathis, A., Gkekas, C., Gastounioti, A., Mantas, G., et al.: Galectin-3, carotid plaque vulnerability, and potential effects of statin therapy. Eur. J. Vasc. Endovasc. Surg. 49(1), 4\u20139 (2015)","journal-title":"European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery."},{"key":"10106_CR26","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.2147\/DMSO.S273029","volume":"13","author":"L Jing","year":"2020","unstructured":"Jing, L., Li, L., Ren, X., Sun, Z., Bao, Z., Yuan, G., et al.: Role of sortilin and matrix vesicles in N\u03b5-Carboxymethyl-Lysine-Induced diabetic atherosclerotic calcification. Diabet. Metab. Synd. Ob.\u00a013, 4141\u20134151 (2020)","journal-title":"Diabetes, metabolic syndrome and obesity : targets and therapy."},{"issue":"1","key":"10106_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcmg.2017.10.012","volume":"11","author":"H Mori","year":"2018","unstructured":"Mori, H., Torii, S., Kutyna, M., Sakamoto, A., Finn, A.V., Virmani, R.: Coronary artery calcification and its progression: What does it really mean? JACC Cardiovasc. Imaging 11(1), 127\u2013142 (2018)","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"12","key":"10106_CR28","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.18632\/aging.204130","volume":"14","author":"L Tian","year":"2022","unstructured":"Tian, L., Wang, Y., Zhang, R.: Galectin-3 induces vascular smooth muscle cells calcification via AMPK\/TXNIP pathway. Aging 14(12), 5086\u20135096 (2022)","journal-title":"Aging"},{"issue":"10302","key":"10106_CR29","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K., Jafar, T.H., Nitsch, D., Neuen, B.L., Perkovic, V.: Chronic kidney disease. Lancet (London, England). 398(10302), 786\u2013802 (2021)","journal-title":"Lancet (London, England)."},{"issue":"5","key":"10106_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000446376","volume":"43","author":"V Desmedt","year":"2016","unstructured":"Desmedt, V., Desmedt, S., Delanghe, J.R., Speeckaert, R., Speeckaert, M.M.: Galectin-3 in renal pathology: More than just an innocent bystander. Am. J. Nephrol. 43(5), 305\u2013317 (2016)","journal-title":"Am J Nephrol."},{"key":"10106_CR31","doi-asserted-by":"crossref","unstructured":"Boutin, L., Depret, F., Gayat, E., Legrand, M., Chadjichristos, C.E.: Galectin-3 in kidney diseases: from an old protein to a new therapeutic target.\u00a0Int. J. Mol. Sci. 23(6) (2022)","DOI":"10.3390\/ijms23063124"},{"issue":"13","key":"10106_CR32","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen, T.K., Knicely, D.H., Grams, M.E.: Chronic kidney disease diagnosis and management: A review. JAMA 322(13), 1294\u20131304 (2019)","journal-title":"JAMA"},{"issue":"9","key":"10106_CR33","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1681\/ASN.2014010093","volume":"26","author":"C Drechsler","year":"2015","unstructured":"Drechsler, C., Delgado, G., Wanner, C., Blouin, K., Pilz, S., Tomaschitz, A., et al.: Galectin-3, renal function, and clinical outcomes: Results from the LURIC and 4D Studies. J. Am. Soc. Nephrol.\u00a026(9), 2213\u20132221 (2015)","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10106_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/hdi.12825","volume":"24","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Chen, Z., Ma, X., Yu, H., Chen, X.: The predictive value of serum galectin 3 for abdominal aortic calcification in maintenance hemodialysis patients: A prospective cohort study. Hemodialysis international International Symposium on Home Hemodialysis. 24(2), 212\u2013220 (2020)","journal-title":"Hemodialysis international International Symposium on Home Hemodialysis."},{"issue":"6","key":"10106_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/1358863X20953481","volume":"25","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Yin, K., Ni, Z.: Galectin-3 and abdominal aortic calcification in patients on hemodialysis. Vascular medicine (London, England). 25(6), 575\u2013576 (2020)","journal-title":"Vascular medicine (London, England)."},{"key":"10106_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000349972","volume":"182","author":"JA Tumlin","year":"2013","unstructured":"Tumlin, J.A., Costanzo, M.R., Chawla, L.S., Herzog, C.A., Kellum, J.A., McCullough, P.A., et al.: Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol. 182, 158\u2013173 (2013)","journal-title":"Contrib. Nephrol."},{"issue":"3","key":"10106_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ckj\/sfaa089","volume":"13","author":"K Iseri","year":"2020","unstructured":"Iseri, K., Dai, L., Chen, Z., Qureshi, A.R., Brismar, T.B., Stenvinkel, P., et al.: Bone mineral density and mortality in end-stage renal disease patients. Clin. Kidney J. 13(3), 307\u2013321 (2020)","journal-title":"Clin. Kidney J."},{"issue":"23","key":"10106_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"35","author":"P Lanzer","year":"2014","unstructured":"Lanzer, P., Boehm, M., Sorribas, V., Thiriet, M., Janzen, J., Zeller, T., et al.: Medial vascular calcification revisited: review and perspectives. Eur. Heart J. 35(23), 1515\u20131525 (2014)","journal-title":"Eur. Heart J."},{"issue":"2","key":"10106_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2012.01.019","volume":"221","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Jiang, Y., Liu, N., Ren, L., Zhu, Y., An, Y., et al.: Advanced glycation end-product N\u03b5-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis 221(2), 387\u2013396 (2012)","journal-title":"Atherosclerosis"},{"issue":"3","key":"10106_CR40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/FJC.0000000000000788","volume":"75","author":"W Gu","year":"2020","unstructured":"Gu, W., Wang, Z., Sun, Z., Bao, Z., Zhang, L., Geng, Y., et al.: Role of NFATc1 in the bone-vascular axis calcification paradox. J. Cardiovasc. Pharmacol. 75(3), 200\u2013207 (2020)","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10106_CR41","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/jim-2015-000041","volume":"64","author":"G Aksan","year":"2016","unstructured":"Aksan, G., Gedikli, \u00d6., Keskin, K., Nar, G., \u0130nci, S., Y\u0131ld\u0131z, S.S., et al.: Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis? Journal of investigative medicine\u202f: the official publication of the American Federation for Clinical Research. 64(3), 764\u2013770 (2016)","journal-title":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research."},{"issue":"6","key":"10106_CR42","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/glycob\/cwt006","volume":"23","author":"AC MacKinnon","year":"2013","unstructured":"MacKinnon, A.C., Liu, X., Hadoke, P.W., Miller, M.R., Newby, D.E., Sethi, T.: Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. Glycobiology 23(6), 654\u2013663 (2013)","journal-title":"Glycobiology"},{"key":"10106_CR43","doi-asserted-by":"crossref","unstructured":"\u015awi\u0119cki, P., Sawicki, R., Knapp, M., Kami\u0144ski, K.A., Ptaszy\u0144ska-Kopczy\u0144ska, K., Sobkowicz, B., et al.: Galectin-3 as the prognostic factor of adverse cardiovascular events in long-term follow up in patients after myocardial infarction-a pilot study.\u00a0J. Clin. Med.\u00a09(6) (2020)","DOI":"10.3390\/jcm9061640"},{"issue":"5","key":"10106_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152816","volume":"11","author":"R Mart\u00edn-Reyes","year":"2016","unstructured":"Mart\u00edn-Reyes, R., Franco-Pel\u00e1ez, J.A., Lorenzo, \u00d3., Gonz\u00e1lez-Casaus, M.L., Pello, A.M., Ace\u00f1a, \u00c1., et al.: Plasma levels of monocyte chemoattractant protein-1, n-Terminal Fragment of brain natriuretic peptide and calcidiol are independently associated with the complexity of coronary artery disease. PLoS ONE 11(5), e0152816 (2016)","journal-title":"PLoS ONE"},{"issue":"1","key":"10106_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/0003319718780772","volume":"70","author":"A Oyenuga","year":"2019","unstructured":"Oyenuga, A., Folsom, A.R., Fashanu, O., Aguilar, D., Ballantyne, C.M.: Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study. Angiology 70(1), 47\u201355 (2019)","journal-title":"Angiology"},{"issue":"4","key":"10106_CR46","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.7150\/thno.50247","volume":"11","author":"Z Varasteh","year":"2021","unstructured":"Varasteh, Z., De Rose, F., Mohanta, S., Li, Y., Zhang, X., Miritsch, B., et al.: Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using ((89)Zr)-DFO- Galectin3-F(ab\u2019)(2) mAb. Theranostics. 11(4), 1864\u20131876 (2021)","journal-title":"Theranostics."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-023-10106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-023-10106-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-023-10106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T16:09:29Z","timestamp":1701965369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-023-10106-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10106"],"URL":"https:\/\/doi.org\/10.1007\/s10719-023-10106-x","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}